NSE filing, NSE: CARERATING. Summary written from the filing by ALFA Finder's alert engine.
CARE Ratings Ltd: key numbers
- Share price
- ₹1,611.60
- Market cap
- ₹4,856 Cr
- Revenue (annual)
- ₹473.1 Cr
- Net profit (annual)
- ₹171.2 Cr
- P/E (TTM)
- 27.3×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 23.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CARE Ratings Ltd
All →CARE Ratings Merger & Restructuring
CARE Ratings executed SPAs to sell 9.90% stakes each in subsidiary CareEdge Global IFSC to SBI and NSE IFSC. CARE will retain 80.20% post-closing.
CARE Ratings Other Announcement
CARE Ratings Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
CARE Ratings Board Meeting Date
CARE Ratings Limited intimated a board meeting scheduled for 29 October 2026 to consider unaudited half-yearly financial results and an interim dividend. No figures or decisions have been made yet.
CARE Ratings Employee Stock Options
CARE Ratings Limited allotted 14,200 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings Earnings Call Transcript: Key Takeaways
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
CARE Ratings Employee Stock Options
CARE Ratings has allotted 24,500 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date